Josu de la Fuente is a Consultant Haematologist at Imperial College Healthcare NHS Trust and Professor of Practice (Cellular and Gene Therapies) of Imperial College London. He was appointed Director of the Paediatric Blood & Marrow Transplant Programme in 2006, specialising in transplantation for haemoglobinopathies and bone marrow failure, and being innovative in the use of alternative donors. He is the Secretary of the Haemoglobinopathy Working Party of EBMT & Co-Director of the Vanderbilt Global Haplo-identical learning collaborative for Cure (VGC2). He is principal investigator and member of the steering committee of several gene therapy trials in sickle cell disease and thalassaemia.